0001209191-17-016549.txt : 20170302
0001209191-17-016549.hdr.sgml : 20170302
20170302161726
ACCESSION NUMBER: 0001209191-17-016549
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170301
FILED AS OF DATE: 20170302
DATE AS OF CHANGE: 20170302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC
CENTRAL INDEX KEY: 0001108109
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 133893191
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
BUSINESS PHONE: 615-465-7000
MAIL ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
FORMER COMPANY:
FORMER CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC/
DATE OF NAME CHANGE: 20000229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McClellan III John W
CENTRAL INDEX KEY: 0001673001
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15925
FILM NUMBER: 17659012
MAIL ADDRESS:
STREET 1: 4000 MERIDIAN BLVD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-01
0
0001108109
COMMUNITY HEALTH SYSTEMS INC
CYH
0001673001
McClellan III John W
4000 MERIDIAN BOULEVARD
FRANKLIN
TN
37067
0
1
0
0
Division President
Common Stock
2017-03-01
4
A
0
20000
0.00
A
43228
D
Common Stock
2017-03-01
4
F
0
1986
9.19
D
41242
D
Performance Based Restricted
0.00
2017-03-01
4
A
0
20000
0.00
A
2020-03-01
2027-02-28
Common Stock
20000
20000
D
Stock Options (Right to Buy)
21.69
2010-05-19
2019-05-18
Common Stock
1000
1000
D
Stock Options (Right to Buy)
30.32
2011-02-24
2020-02-23
Common Stock
1000
1000
D
Stock Options (Right to Buy)
34.38
2012-02-23
2021-02-22
Common Stock
1000
1000
D
Stock Options (Right to Buy)
17.49
2013-02-16
2022-02-15
Common Stock
1000
1000
D
The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
The vesting of 80% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Growth between January 1, 2017 and December 31, 2019 (the "Performance Period"). The vesting of the remaining 20% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Adjusted EPS for the Performance Period. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Adjusted EPS criteria, as applicable, will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the Performance Period.
Christopher G. Cobb, Attorney in Fact for John W McClellan III
2017-03-02